• The disclosure is an intimation of scheduled Analyst/Institutional Investor Meetings, filed pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
  • The company's management will participate in two group meetings:
  • Organized by: Jefferies India Forum 2026

Date: September 17, 2026

Place: Gurugram

Mode: In Person

  • Organized by: Kotak Healthcare Forum 2026

Date: September 18, 2026

Place: Mumbai

Mode: In Person

  • The stated purpose is for the company's management to meet investors and analysts.
  • The company explicitly states that no unpublished price sensitive information (UPSI) is proposed to be shared during these meetings.
  • The schedule is subject to change in case of any unforeseen circumstances on the part of analysts, investors, or the company.
  • No specific management participants or their designations are listed in the disclosure.
  • The disclosure does not indicate that any presentation, earnings deck, transcript, or recording will be made available.

Additional Notes Section

  • The disclosure is a formal letter of intimation addressed to the General Manager, Dept. of Corporate Services, BSE Limited, and the Manager, Listing Department, National Stock Exchange of India Limited.
  • It bears the company reference number: GHL/2026-27/EXCH/53.
  • The letter is digitally signed by Rahul Ranjan, Company Secretary & Compliance Officer (Membership No. A17035).
  • No financial data, guidance, or strategic updates were disclosed in this announcement.
  • No attachments, such as presentation decks or invites, were mentioned as being included.